HENRY FORD HEALTH SYSTEM
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1915-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.henryford.com
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Phase 2
Completed
- Conditions
- Pancreas Neoplasm Malignant Resectable
- Interventions
- Drug: Folfox6Drug: GemcitabineRadiation: Radiation TherapyProcedure: Pancreaticoduodenectomy with retroperitoneal lymphadenectomy
- First Posted Date
- 2014-09-17
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 24
- Registration Number
- NCT02243358
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
Not Applicable
Completed
- Conditions
- Hidradenitis Suppurativa
- Interventions
- Procedure: Surgical DeroofingProcedure: CO2 (carbon dioxide) laser
- First Posted Date
- 2014-06-16
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 20
- Registration Number
- NCT02163746
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy
Completed
- Conditions
- Prodromal Bone DeteriorationOsteoporosisAtypical Femoral Fractures
- Interventions
- Other: 500 without BP treatmentOther: 500 with BP treatment
- First Posted Date
- 2014-06-04
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 738
- Registration Number
- NCT02155595
- Locations
- 🇺🇸
Henry Ford Medical Center, New Center One, Detroit, Michigan, United States
Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions
Not Applicable
Completed
- Conditions
- Chronic Obstructive Pulmonary DiseaseExacerbation of Chronic Obstructive Pulmonary Disease
- Interventions
- Behavioral: Bundle tool
- First Posted Date
- 2014-05-12
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 172
- Registration Number
- NCT02135744
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease
Phase 2
- Conditions
- Parkinson's DiseaseFreezing of GaitCognitive Ability, General
- Interventions
- Drug: DroxidopaDrug: sugar pill
- First Posted Date
- 2014-02-19
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 20
- Registration Number
- NCT02066571
- Locations
- 🇺🇸
Henry Ford Hospital, West Bloomfield, West Bloomfield, Michigan, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke
Completed
- Conditions
- Ischemic Stroke
- First Posted Date
- 2014-02-06
- Last Posted Date
- 2017-01-04
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 88
- Registration Number
- NCT02056821
- Locations
- 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States
Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP
Not Applicable
- Conditions
- Depigmented ScarsVitiligoDepigmentation
- Interventions
- Procedure: MKTP (melanocyte keratinocyte transplant procedure)Device: Collagen DressingDevice: Vaseline Impregnated GauzeDevice: DermabrasionDevice: Carbon Dioxide Laser
- First Posted Date
- 2014-01-16
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 20
- Registration Number
- NCT02038257
- Locations
- 🇺🇸
Henry Ford Dermatology, Detroit, Michigan, United States
Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit
Phase 4
- Conditions
- Opioid Use, Unspecified With WithdrawalOpioid-Induced DisordersDelirium
- Interventions
- Drug: PlaceboDrug: Methadone
- First Posted Date
- 2014-01-01
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 46
- Registration Number
- NCT02025855
- Locations
- 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States
Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)
Phase 2
Withdrawn
- Conditions
- Subarachnoid HemorrhageCerebral AneurysmVasospasm, Intracranial
- Interventions
- First Posted Date
- 2013-12-13
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Henry Ford Health System
- Registration Number
- NCT02011321
- Locations
- 🇺🇸
Henry Ford hospital, Detroit, Michigan, United States
Cardiology-Emergency Medicine Cardiac Biomarker Research Initiative
Completed
- Conditions
- Acute Coronary Syndrome
- Interventions
- Other: OBSERVATIONAL REGISTRY
- First Posted Date
- 2013-11-15
- Last Posted Date
- 2015-07-31
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 575
- Registration Number
- NCT01984853
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath